IGeneX is a leader in diagnostic testing for Lyme disease and other tick-borne illnesses. Founded in 1991 by Dr. Nick Harris in Milpitas, California, the company focuses on developing sensitive and accurate tests to improve the diagnosis of these diseases. With over 30 years of experience, IGeneX has expanded its testing capabilities under the guidance of Dr. Jyotsna Shah, who has contributed significantly to infectious disease diagnostics. The company offers a wide range of diagnostic services, including tests for Lyme disease, Tick-Borne Relapsing Fever (TBRF), Babesiosis, and Bartonellosis. Their testing menu features molecular and immunological tests, Multi-Species ImmunoBlots, and IgXSpot tests. IGeneX provides various collection kits for blood, urine, and other samples, ensuring that results are delivered to healthcare providers within 7-10 business days. With a commitment to research and a patient-first approach, IGeneX aims to deliver the most comprehensive and accurate testing available for tick-borne diseases.